Certara
tam segmentation | Certara
Company
Deck Type
Sector
Industry
Deck date
May 2022
Slide
12 of 30
Related slides by other companies
Alkermes
Investor Conference
January 2024
proven drug development capabilities | Alkermes
Genetron
Results
June 2022
in drug development services for i a | Genetron
ATAI
Investor Presentation
October 2022
mental health disorders have become one of global health burdens depression rates of us adults saw a increase since the onset of the covid pandemic as a response to the technical risks associated with drug development focuses on compound classes with prior evidence in humans and utilizes a decentralized drug development process active programs drug and discovery programs and enabling technologies focusing on potentially disease modifying therapies validation of operating model of compass pathways and validating license deal between perception we have a strong cash position of as of june and access to up to from term loan facility with giving cash runway into life sciences healing so that everyone everywhere can live more life | ATAI
Genetron
Results
August 2021
in drug development services for cay arm | Genetron
Other recent decks by Certara
See all presentations (2 decks)
Investor Day
December 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io